{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T09:17:03Z","timestamp":1772615823042,"version":"3.50.1"},"reference-count":143,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","pathologyjournal.rcpa.edu.au","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.pathol.2020.09.014","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T07:06:38Z","timestamp":1604387198000},"page":"67-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Stage T1 bladder cancer: diagnostic criteria and pitfalls"],"prefix":"10.1016","volume":"53","author":[{"given":"Antonio","family":"Lopez-Beltran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6049-5293","authenticated-orcid":false,"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2020.09.014_bib1","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1080\/00313020310001619127","article-title":"Stage pT1 bladder carcinoma: diagnostic criteria, pitfalls and prognostic significance","volume":"35","author":"Lopez-Beltran","year":"2003","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2020.09.014_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/00365598709180320","article-title":"Recurrence, progression and survival in bladder cancer. A retrospective analysis of 232 patients with greater than or equal to 5-year follow-up","volume":"21","author":"Malmstrom","year":"1987","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.pathol.2020.09.014_bib3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/modpathol.2009.1","article-title":"Staging and reporting of urothelial carcinoma of the urinary bladder","volume":"22","author":"Cheng","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib4","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1002\/(SICI)1097-0142(20000515)88:10<2326::AID-CNCR17>3.0.CO;2-T","article-title":"Predicting the survival of bladder carcinoma patients treated with radical cystectomy","volume":"88","author":"Cheng","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2020.09.014_bib5","series-title":"Tumours of the Urinary and Male Reproductive System","article-title":"WHO Classification of Tumours. Pathology and Genetics:","author":"Eble","year":"2004"},{"key":"10.1016\/j.pathol.2020.09.014_bib6","series-title":"WHO Classification of Tumours of the Urinary System and Male Genital Organs","author":"Moch","year":"2016"},{"key":"10.1016\/j.pathol.2020.09.014_bib7","series-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2018"},{"key":"10.1016\/j.pathol.2020.09.014_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41585-018-0105-y","article-title":"T1 bladder cancer: current considerations for diagnosis and management","volume":"16","author":"Jordan","year":"2019","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.pathol.2020.09.014_bib9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/his.13734","article-title":"Staging of bladder cancer","volume":"74","author":"Magers","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2020.09.014_bib10","first-page":"154","article-title":"Early cystectomy for clinical stage T1 transitional cell carcinoma of the bladder","volume":"15","author":"Esrig","year":"1997","journal-title":"Semin Urol Oncol"},{"key":"10.1016\/j.pathol.2020.09.014_bib11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1200\/JCO.2014.57.6967","article-title":"Improving selection criteria for early cystectomy in high-grade T1 bladder cancer: a meta-analysis of 15,215 patients","volume":"33","author":"Martin-Doyle","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2020.09.014_bib12","first-page":"688","article-title":"A\u00a0practical approach to bladder sampling and diagnostic reporting of pathological findings","volume":"93","author":"Lopez-Beltran","year":"2001","journal-title":"Pathologica"},{"key":"10.1016\/j.pathol.2020.09.014_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00125480-200007010-00004","article-title":"pT1 urothelial carcinoma of the bladder: criteria for diagnosis, pitfalls, and clinical implications","volume":"7","author":"Jimenez","year":"2000","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib14","series-title":"Bladder Pathology","author":"Cheng","year":"2012"},{"key":"10.1016\/j.pathol.2020.09.014_bib15","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0094-0143(05)70197-X","article-title":"Diagnosis and grading of bladder cancer and associated lesions","volume":"26","author":"Bostwick","year":"1999","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.pathol.2020.09.014_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00428-020-02808-6","article-title":"pT1 high-grade bladder cancer: histologic criteria, pitfalls in the assessment of invasion, and substaging","volume":"477","author":"Raspollini","year":"2020","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2020.09.014_bib17","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/modpathol.2014.158","article-title":"Update for the practicing pathologist: the International Consultation on Urologic Disease-European Association of Urology consultation on bladder cancer","volume":"28","author":"Amin","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib18","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41379-019-0403-9","article-title":"Dataset for the reporting of urinary tract carcinoma-biopsy and transurethral resection specimen: recommendations from the International Collaboration on Cancer Reporting (ICCR)","volume":"33","author":"Varma","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1309\/94B6-8VFB-MN9J-1NF5","article-title":"Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens","volume":"113","author":"Cheng","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib20","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0090-4295(99)00595-6","article-title":"Predicting extravesical extension of bladder carcinoma: a novel method based on micrometer measurement of the depth of invasion in transurethral resection specimens","volume":"55","author":"Cheng","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.pathol.2020.09.014_bib21","first-page":"265","article-title":"Histology and fine structure of the muscularis mucosae of the human urinary bladder","volume":"136","author":"Dixon","year":"1983","journal-title":"J\u00a0Anat"},{"key":"10.1016\/j.pathol.2020.09.014_bib22","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/00000478-198709000-00002","article-title":"Muscularis mucosa of urinary bladder. Importance for staging and treatment","volume":"11","author":"Ro","year":"1987","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/00365599209180877","article-title":"The muscularis mucosae of the human urinary bladder. Implications for tumor staging on biopsies","volume":"26","author":"Engel","year":"1992","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.pathol.2020.09.014_bib24","series-title":"Urologic Surgical Pathology","article-title":"Nonneoplastic disorders of the urinary bladder","author":"Lopez-Beltran","year":"2020"},{"key":"10.1016\/j.pathol.2020.09.014_bib25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.humpath.2020.01.004","article-title":"The applicability and utility of immunohistochemical biomarkers in bladder pathology","volume":"98","author":"Akgul","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/PAI.0b013e3181e04816","article-title":"Clinical utility of immunohistochemistry in the diagnoses of urinary bladder neoplasia","volume":"18","author":"Hodges","year":"2010","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.pathol.2020.09.014_bib27","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.5858\/arpa.2014-0078-RA","article-title":"The application of immunohistochemical biomarkers in urologic surgical pathology","volume":"138","author":"Wilkerson","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.pathol.2020.09.014_bib28","series-title":"Urologic Surgical Pathology","author":"Cheng","year":"2020"},{"key":"10.1016\/j.pathol.2020.09.014_bib29","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/PAS.0000000000000254","article-title":"Best practices recommendations in the application of immunohistochemistry in urologic pathology: report from the International Society of Urological Pathology consensus conference","volume":"38","author":"Amin","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib30","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/PAS.0b013e3181da7650","article-title":"Diagnostic use of antibody to smoothelin in the recognition of muscularis propria in transurethral resection of urinary bladder tumor (TURBT) specimens","volume":"34","author":"Paner","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib31","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/modpathol.2009.9","article-title":"Differential expression of immunohistochemical markers in bladder smooth muscle and myofibroblasts, and the potential utility of desmin, smoothelin, and vimentin in staging of bladder carcinoma","volume":"22","author":"Council","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib32","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/PAS.0b013e3181ce5066","article-title":"Pitfalls in the use of smoothelin to identify muscularis propria invasion by urothelial carcinoma","volume":"34","author":"Miyamoto","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib33","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.humpath.2012.01.008","article-title":"Histologic grading of urothelial carcinoma: a reappraisal","volume":"43","author":"Cheng","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib34","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.euf.2018.01.003","article-title":"Grading of urothelial carcinoma and the new \u201cWorld Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016\u201d","volume":"5","author":"Comperat","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.pathol.2020.09.014_bib35","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.eururo.2006.10.037","article-title":"Histologic grading of noninvasive papillary urothelial neoplasms","volume":"51","author":"MacLennan","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2020.09.014_bib36","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/PAS.0b013e318253d6e0","article-title":"Invasive low-grade papillary urothelial carcinoma: a clinicopathologic analysis of 41 cases","volume":"36","author":"Toll","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib37","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/his.14192","article-title":"Reappraisal of the papillary urothelial neoplasm of low malignant potential (PUNLMP)","volume":"77","author":"Jones","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2020.09.014_bib38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00428-001-0577-6","article-title":"Preneoplastic non-papillary lesions and conditions of the urinary bladder: an update based on the Ancona International Consultation","volume":"440","author":"Lopez-Beltran","year":"2002","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2020.09.014_bib39","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.humpath.2009.11.018","article-title":"Invasive micropapillary urothelial carcinoma of the bladder","volume":"41","author":"Lopez-Beltran","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib40","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.urolonc.2019.10.013","article-title":"Micropapillary urothelial carcinoma of urinary bladder displays immunophenotypic features of luminal and p53-like subtypes and is not a variant of adenocarcinoma","volume":"38","author":"Yang","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.pathol.2020.09.014_bib41","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.humpath.2006.05.009","article-title":"Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications","volume":"37","author":"Lopez-Beltran","year":"2006","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib42","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1097\/PAS.0b013e3182159dec","article-title":"Sarcomatoid carcinoma of the urinary bladder: the final common pathway of urothelial carcinoma dedifferentiation","volume":"35","author":"Cheng","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib43","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0094-0143(05)70199-3","article-title":"Bladder treatment. Immunotherapy and chemotherapy","volume":"26","author":"Lopez-Beltran","year":"1999","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.pathol.2020.09.014_bib44","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/jcp.55.9.641","article-title":"Changes produced in the urothelium by traditional and newer therapeutic procedures for bladder cancer","volume":"55","author":"Lopez-Beltran","year":"2002","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib45","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/his.13090","article-title":"Iatrogenic changes in the urinary tract","volume":"70","author":"Lopez-Beltran","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2020.09.014_bib46","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.humpath.2007.03.017","article-title":"Soft tissue tumors of the urinary bladder, Part I: myofibroblastic proliferations, benign neoplasms, and tumors of uncertain malignant potential","volume":"38","author":"Lott","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib47","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.humpath.2007.03.016","article-title":"Soft tissue tumors of the urinary bladder Part II: malignant neoplasms","volume":"38","author":"Lott","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib48","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1097\/PAS.0b013e3180588283","article-title":"Further characterization of the muscle layers and lamina propria of the urinary bladder by systematic histologic mapping: implications for pathologic staging of invasive urothelial carcinoma","volume":"31","author":"Paner","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib49","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00428-011-1076-z","article-title":"Detection of smoothelin expression in the urinary bladder is strongly dependent on pretreatment conditions: a critical analysis with possible consequences for cancer staging","volume":"458","author":"Lindh","year":"2011","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2020.09.014_bib50","first-page":"609","article-title":"Observation on microinvasive transitional cell carcinoma of the urinary bladder","volume":"1","author":"Farrow","year":"1982","journal-title":"Clin Oncol"},{"key":"10.1016\/j.pathol.2020.09.014_bib51","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/PAS.0b013e31823dafd3","article-title":"Prognostic significance in substaging of T1 urinary bladder urothelial carcinoma on transurethral resection","volume":"36","author":"Chang","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib52","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.humpath.2005.06.017","article-title":"A\u00a0new system for substaging pT1 papillary bladder cancer: a prognostic evaluation","volume":"36","author":"van der Aa","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib53","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1365-2559.2011.03989.x","article-title":"Substaging by estimating the size of invasive tumour can improve risk stratification in pT1 urothelial bladder cancer-evaluation of a large hospital-based single-centre series","volume":"59","author":"Bertz","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2020.09.014_bib54","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.eururo.2011.10.026","article-title":"A\u00a0new and highly prognostic system to discern T1 bladder cancer substage","volume":"61","author":"van Rhijn","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2020.09.014_bib55","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.critrevonc.2010.01.005","article-title":"Diagnosis, evaluation and treatment of carcinoma in situ of the urinary bladder: the state of the art","volume":"76","author":"Williamson","year":"2010","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.pathol.2020.09.014_bib56","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1200\/JCO.1999.17.10.3182","article-title":"Predicting cancer progression in patients with stage T1 bladder carcinoma","volume":"17","author":"Cheng","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2020.09.014_bib57","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/(SICI)1097-0142(19990915)86:6<1035::AID-CNCR20>3.0.CO;2-D","article-title":"Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer: a new proposal","volume":"86","author":"Cheng","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2020.09.014_bib58","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/03008880802325226","article-title":"Bladder cancer: clinical and pathological profile","author":"Lopez-Beltran","year":"2008","journal-title":"Scand J Urol Nephrol Suppl"},{"key":"10.1016\/j.pathol.2020.09.014_bib59","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/his.13247","article-title":"Stalk versus base invasion in pT1 papillary cancers of the bladder: improved substaging system predicting the risk of progression","volume":"71","author":"Lawless","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2020.09.014_bib60","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/his.13752","article-title":"Variants and new entities of bladder cancer","volume":"74","author":"Lopez-Beltran","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2020.09.014_bib61","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.euf.2019.09.003","article-title":"What is the significance of variant histology in urothelial carcinoma?","volume":"6","author":"Lobo","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.pathol.2020.09.014_bib62","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.humpath.2009.01.001","article-title":"Plasmacytoid urothelial carcinoma of the bladder","volume":"40","author":"Lopez-Beltran","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib63","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.urolonc.2014.03.008","article-title":"Plasmacytoid variant urothelial bladder cancer: is it time to update the treatment paradigm?","volume":"32","author":"Kaimakliotis","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.pathol.2020.09.014_bib64","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.urology.2013.12.035","article-title":"Plasmacytoid bladder cancer: variant histology with aggressive behavior and a new mode of invasion along fascial planes","volume":"83","author":"Kaimakliotis","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.pathol.2020.09.014_bib65","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.humpath.2019.04.012","article-title":"Plasmacytoid\/diffuse urothelial carcinoma: a single-institution immunohistochemical and molecular study of 69 patients","volume":"90","author":"Perrino","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib66","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.eururo.2018.11.052","article-title":"Micropapillary urothelial carcinoma of the bladder: a systematic review and meta-analysis of disease characteristics and treatment outcomes","volume":"75","author":"Abufaraj","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2020.09.014_bib67","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1464-410X.2010.09853.x","article-title":"Urothelial lesions with inverted growth patterns: histogenesis, molecular genetic findings, differential diagnosis and clinical management","volume":"107","author":"Hodges","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.pathol.2020.09.014_bib68","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/his.12214","article-title":"An interobserver reproducibility study on invasiveness of bladder cancer using virtual microscopy and heatmaps","volume":"63","author":"Comperat","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2020.09.014_bib69","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1365-2559.2011.03784.x","article-title":"Handling and reporting of transurethral resection specimens of the bladder in Europe: a web-based survey by the European Network of Uropathology (ENUP)","volume":"58","author":"Lopez-Beltran","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2020.09.014_bib70","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.humpath.2009.07.002","article-title":"Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features","volume":"41","author":"Hodges","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib71","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00428-004-1039-8","article-title":"Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis. A joint proposal of the European Society of Uropathology and the Uropathology Working Group","volume":"445","author":"Lopez-Beltran","year":"2004","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2020.09.014_bib72","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/his.12345","article-title":"Microcystic urothelial carcinoma: morphology, immunohistochemistry and clinical behaviour","volume":"64","author":"Lopez Beltran","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2020.09.014_bib73","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00428-014-1601-y","article-title":"Clinicopathological characteristics and outcome of nested carcinoma of the urinary bladder","volume":"465","author":"Beltran","year":"2014","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2020.09.014_bib74","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.humpath.2015.06.010","article-title":"Inverted urothelial carcinoma: a series of 12 cases with a wide morphologic spectrum overlapping with the large nested variant","volume":"46","author":"Brimo","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib75","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/PAS.0000000000001453","article-title":"Report from the International Society of Urological Pathology (ISUP) consultation conference on molecular pathology of urogenital cancers. II. Molecular pathology of bladder cancer: progress and challenges","volume":"44","author":"Warrick","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib76","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/his.12920","article-title":"Telomerase reverse transcriptase (TERT) promoter mutation analysis of benign, malignant and reactive urothelial lesions reveals a subpopulation of inverted papilloma with immortalizing genetic change","volume":"69","author":"Cheng","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2020.09.014_bib77","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/his.14038","article-title":"The expanding molecular and mutational landscape of nested variant of urothelial carcinoma","volume":"76","author":"Levy","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2020.09.014_bib78","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/path.5307","article-title":"Distinct mutational landscape of inverted urothelial papilloma","volume":"249","author":"Akgul","year":"2019","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib79","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.eururo.2016.12.008","article-title":"TERT promoter mutations occur frequently in urothelial papilloma and papillary urothelial neoplasm of low malignant potential","volume":"71","author":"Cheng","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2020.09.014_bib80","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.euf.2017.03.007","article-title":"Small-cell carcinomas of the urinary bladder and prostate: TERT promoter mutation status differentiates sites of malignancy and provides evidence of common clonality between small-cell carcinoma of the urinary bladder and urothelial carcinoma","volume":"4","author":"Priemer","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.pathol.2020.09.014_bib81","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2217\/fon-2016-0414","article-title":"TERT promoter mutation status in sarcomatoid urothelial carcinomas of the upper urinary tract","volume":"13","author":"Wang","year":"2017","journal-title":"Future Oncol"},{"key":"10.1016\/j.pathol.2020.09.014_bib82","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrurol.2018.2","article-title":"A\u00a0practical guide to bladder cancer pathology","volume":"15","author":"Comperat","year":"2018","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.pathol.2020.09.014_bib83","first-page":"989","article-title":"The nested variant of transitional cell carcinoma: an aggressive neoplasm with innocuous histology","volume":"9","author":"Drew","year":"1996","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib84","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.humpath.2012.08.011","article-title":"Immunohistochemistry as an adjunct in the differential diagnosis of radiation-induced atypia versus urothelial carcinoma in situ of the bladder: a study of 45 cases","volume":"44","author":"Oliva","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib85","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00000478-200103000-00010","article-title":"Morphologic expressions of urothelial carcinoma in situ: a detailed evaluation of its histologic patterns with emphasis on carcinoma in situ with microinvasion","volume":"25","author":"McKenney","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib86","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.humpath.2010.12.024","article-title":"Flat urothelial carcinoma in situ of the bladder with glandular differentiation","volume":"42","author":"Lopez-Beltran","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib87","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/PAS.0000000000001192","article-title":"Patterns of urachal remnant involvement by urothelial carcinoma: intraluminal noninvasive spread can mimic a deep-seated bladder invasion","volume":"43","author":"Han","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib88","first-page":"161","article-title":"Lamina propria microinvasion of bladder tumors, incidence on stage allocation (pTa vs pT1): recommended approach","volume":"11","year":"1993","journal-title":"World J Urol"},{"key":"10.1016\/j.pathol.2020.09.014_bib89","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1464-410X.1988.tb04325.x","article-title":"Should pT1 transitional cell cancers of the bladder still be classified as superficial?","volume":"62","author":"Abel","year":"1988","journal-title":"Br J Urol"},{"key":"10.1016\/j.pathol.2020.09.014_bib90","first-page":"1291","article-title":"Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder","volume":"169","author":"Bol","year":"2003","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pathol.2020.09.014_bib91","first-page":"1533","article-title":"The role and impact of pathology review on stage and grade assessment of stages Ta and T1 bladder tumors: a combined analysis of 5 European Organization for Research and Treatment of Cancer Trials","volume":"164","author":"Van Der Meijden","year":"2000","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pathol.2020.09.014_bib92","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1464-410x.2000.00356.x","article-title":"Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer","volume":"85","author":"Tosoni","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.pathol.2020.09.014_bib93","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1023\/A:1020553812554","article-title":"Staging error in the bladder tumor: the correlation between stage of TUR and cystectomy","volume":"33","author":"Bayraktar","year":"2002","journal-title":"Int J Urol Nephrol"},{"key":"10.1016\/j.pathol.2020.09.014_bib94","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0302-2838(02)00368-8","article-title":"Value of immunohistochemistry in staging T1 urothelial bladder carcinoma","volume":"42","author":"Mhawech","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2020.09.014_bib95","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.euf.2016.12.011","article-title":"Role of restaging transurethral resection for T1 non-muscle invasive bladder cancer: a systematic review and meta-analysis","volume":"4","author":"Naselli","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.pathol.2020.09.014_bib96","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0090-4295(02)01920-9","article-title":"Impact of a second transurethral resection on the staging of T1 bladder cancer","volume":"60","author":"Dalbagni","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.pathol.2020.09.014_bib97","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000472760","article-title":"Prognosis of bladder cancer. I. Risk factors in superficial transitional cell carcinoma","volume":"13","author":"Pagano","year":"1987","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2020.09.014_bib98","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.eururo.2018.02.014","article-title":"Repeat transurethral resection in non-muscle-invasive bladder cancer: a systematic review","volume":"73","author":"Cumberbatch","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2020.09.014_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.euo.2020.06.010","article-title":"Best practices to optimise quality and outcomes of transurethral resection of bladder tumours","author":"Mostafid","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.pathol.2020.09.014_bib100","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0302-2838(03)00040-X","article-title":"The value of a second transurethral resection in evaluating patients with bladder tumors","volume":"43","author":"Miladi","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2020.09.014_bib101","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000063941","article-title":"Microstaging of pT1 transitional cell carcinoma of the bladder: does it really differentiate two populations with different prognoses?","volume":"69","author":"Sozen","year":"2002","journal-title":"Urol Int"},{"key":"10.1016\/j.pathol.2020.09.014_bib102","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/PAS.0b013e3182796e72","article-title":"Does muscularis mucosae invasion in extensively lamina propria-invasive high-grade papillary urothelial carcinoma provide additional prognostic information?","volume":"37","author":"Pan","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib103","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/ajcp\/91.5.575","article-title":"Invasive carcinomas of the urinary bladder. Evaluation of tunica muscularis mucosae involvement","volume":"91","author":"Keep","year":"1989","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib104","first-page":"1035","article-title":"Is microstaging of early invasive cancer of the urinary bladder possible or useful?","volume":"9","author":"Platz","year":"1996","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0090-4295(95)96490-8","article-title":"Muscularis mucosa differentiates two populations with different prognosis in stage T1 bladder cancer","volume":"45","author":"Angulo","year":"1995","journal-title":"Urology"},{"key":"10.1016\/j.pathol.2020.09.014_bib106","first-page":"2069","article-title":"Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review","volume":"189","author":"Roupret","year":"2013","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pathol.2020.09.014_bib107","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4111\/kju.2012.53.5.317","article-title":"Prognostic significance of substaging according to the depth of lamina propria invasion in primary T1 transitional cell carcinoma of the bladder","volume":"53","author":"Lee","year":"2012","journal-title":"Korean J Urol"},{"key":"10.1016\/j.pathol.2020.09.014_bib108","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/0090-4295(94)90134-1","article-title":"Significance of invasion to the muscularis mucosae on the progression of superficial bladder cancer","volume":"43","author":"Hasui","year":"1994","journal-title":"Urology"},{"key":"10.1016\/j.pathol.2020.09.014_bib109","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/1097-0142(19900801)66:3<543::AID-CNCR2820660323>3.0.CO;2-R","article-title":"The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder","volume":"66","author":"Younes","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2020.09.014_bib110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.eururo.2005.04.013","article-title":"Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a\/b\/c) in BCG-treated and BCG-non-treated patients","volume":"48","author":"Orsola","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2020.09.014_bib111","first-page":"800","article-title":"The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study","volume":"157","author":"Holmang","year":"1997","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pathol.2020.09.014_bib112","first-page":"91","article-title":"The influence of the level of lamina propria invasion and the prevalence of p53 nuclear accumulation on survival in stage T1 transitional cell bladder cancer","volume":"159","author":"Hermann","year":"1998","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pathol.2020.09.014_bib113","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.humpath.2012.04.020","article-title":"Prognostic factors in T1 bladder urothelial carcinoma: the value of recording millimetric depth of invasion, diameter of invasive carcinoma, and muscularis mucosa invasion","volume":"44","author":"Brimo","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib114","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.anndiagpath.2013.11.002","article-title":"Measuring the dimension of invasive component in pT1 urothelial carcinoma in transurethral resection specimens can predict time to recurrence","volume":"18","author":"Hu","year":"2014","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib115","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13000-016-0466-6","article-title":"Usefulness of pT1 substaging in papillary urothelial bladder carcinoma","volume":"11","author":"Patriarca","year":"2016","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib116","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.euf.2016.06.004","article-title":"Feasibility and clinical roles of different substaging systems at first and second transurethral resection in patients with T1 high-grade bladder cancer","volume":"4","author":"Colombo","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.pathol.2020.09.014_bib117","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eururo.2014.06.040","article-title":"Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Gu\u00e9rin: results of a retrospective multicenter study of 2451 patients","volume":"67","author":"Gontero","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2020.09.014_bib118","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0000000000000964","article-title":"Analysis of T1 bladder cancer on biopsy and transurethral resection specimens: comparison and ranking of T1 quantification approaches to predict progression to muscularis propria invasion","volume":"42","author":"Leivo","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2020.09.014_bib119","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2469::AID-CNCR24>3.0.CO;2-U","article-title":"Survival of patients with carcinoma in situ of the urinary bladder","volume":"85","author":"Cheng","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2020.09.014_bib120","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.eururo.2014.10.040","article-title":"Diagnosis and management of urothelial carcinoma in situ of the lower urinary tract: a systematic review","volume":"67","author":"Casey","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2020.09.014_bib121","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.urolonc.2014.05.008","article-title":"Presence of lymphovascular invasion in urothelial bladder cancer specimens after transurethral resections correlates with risk of upstaging and survival: a systematic review and meta-analysis","volume":"32","author":"Kim","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.pathol.2020.09.014_bib122","doi-asserted-by":"crossref","first-page":"6533","DOI":"10.1200\/JCO.2005.05.516","article-title":"Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy","volume":"23","author":"Lotan","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2020.09.014_bib123","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/bju.12997","article-title":"Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trial","volume":"116","author":"von Rundstedt","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.pathol.2020.09.014_bib124","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/cas.12990","article-title":"Tumor budding, a novel prognostic indicator for predicting stage progression in T1 bladder cancers","volume":"107","author":"Fukumoto","year":"2016","journal-title":"Cancer Sci"},{"key":"10.1016\/j.pathol.2020.09.014_bib125","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00428-020-02745-4","article-title":"Clinicopathologic analysis of upper urinary tract carcinoma with variant histology","volume":"477","author":"Rolim","year":"2020","journal-title":"Virchows Arch"},{"issue":"19","key":"10.1016\/j.pathol.2020.09.014_bib126","first-page":"30093","article-title":"Does variant histology change management of non-muscle-invasive bladder cancer?","volume":"S2588\u20139311","author":"Burger","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.pathol.2020.09.014_bib127","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.euf.2017.06.013","article-title":"The impact of plasmacytoid variant histology on the survival of patients with urothelial carcinoma of bladder after radical cystectomy","volume":"5","author":"Li","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.pathol.2020.09.014_bib128","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.euo.2019.09.003","volume":"2","author":"Veskim\u00e4e","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.pathol.2020.09.014_bib129","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.eururo.2019.09.035","article-title":"EAU-ESMO Consensus Statements on the management of advanced and variant bladder cancer-an international collaborative multistakeholder effort(\u2020): under the auspices of the EAU-ESMO Guidelines Committees","volume":"77","author":"Witjes","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2020.09.014_bib130","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ) - 2019 update","volume":"76","author":"Babjuk","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2020.09.014_bib131","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ccell.2016.05.004","article-title":"Comprehensive transcriptional analysis of early-stage urothelial carcinoma","volume":"30","author":"Hedegaard","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pathol.2020.09.014_bib132","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00428-019-02593-x","article-title":"Predicting outcomes in non-muscle invasive (Ta\/T1) bladder cancer: the role of molecular grade based on luminal\/basal phenotype","volume":"475","author":"Rebola","year":"2019","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2020.09.014_bib133","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1158\/1078-0432.CCR-04-2095","article-title":"A\u00a0molecular signature in superficial bladder carcinoma predicts clinical outcome","volume":"11","author":"Dyrskjot","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2020.09.014_bib134","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.eururo.2020.06.048","article-title":"Identification of differential tumor subtypes of T1 bladder cancer","volume":"78","author":"Robertson","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2020.09.014_bib135","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.eururo.2017.05.032","article-title":"Next-generation sequencing of nonmuscle invasive bladder cancer reveals potential biomarkers and rational therapeutic targets","volume":"72","author":"Pietzak","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2020.09.014_bib136","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s13402-020-00524-6","article-title":"Pure high-grade papillary urothelial bladder cancer: a luminal-like subgroup with potential for targeted therapy","volume":"43","author":"Schnitzler","year":"2020","journal-title":"Cell Oncol"},{"key":"10.1016\/j.pathol.2020.09.014_bib137","doi-asserted-by":"crossref","first-page":"690","DOI":"10.21037\/atm.2019.10.24","article-title":"PD-L1 assessment in urothelial carcinoma: a practical approach","volume":"7","author":"Eckstein","year":"2019","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.pathol.2020.09.014_bib138","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/14712598.2020.1733965","article-title":"Immunotherapy for urothelial cancer: from the diagnostic pathologist's point of view","volume":"20","author":"Cimadamore","year":"2020","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.pathol.2020.09.014_bib139","doi-asserted-by":"crossref","first-page":"700","DOI":"10.2174\/1389200218666170518162500","article-title":"Targeting the programmed cell death-1 pathway in genitourinary tumors: current progress and future perspectives","volume":"18","author":"Mann","year":"2017","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.pathol.2020.09.014_bib140","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.2217\/fon-2019-0217","article-title":"Predictive biomarkers for immunotherapy in the treatment of advanced urothelial carcinoma: where we stand and where we go","volume":"15","author":"Gevaert","year":"2019","journal-title":"Future Oncol"},{"key":"10.1016\/j.pathol.2020.09.014_bib141","doi-asserted-by":"crossref","first-page":"329","DOI":"10.6004\/jnccn.2020.0011","article-title":"Bladder cancer, version 3.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Flaig","year":"2020","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.pathol.2020.09.014_bib142","first-page":"1129","article-title":"Immunotherapy with checkpoint blockade in the treatment of urothelial carcinoma","volume":"199","author":"Siefker-Radtke","year":"2018","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pathol.2020.09.014_bib143","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.eururo.2003.09.018","article-title":"Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis","volume":"45","author":"Lopez-Beltran","year":"2004","journal-title":"Eur Urol"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302520309430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302520309430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,11]],"date-time":"2021-04-11T22:03:08Z","timestamp":1618178588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302520309430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":143,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0031302520309430"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2020.09.014","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stage T1 bladder cancer: diagnostic criteria and pitfalls","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2020.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}